Skip to main content
Clinical Trials/CTRI/2024/06/069270
CTRI/2024/06/069270
Not Yet Recruiting
Phase 3

A study to evaluate the clinical effectiveness of multigenetic pharmacogenomics guided treatment in drug naive schizophrenics in northern Indian population an open label randomized controlled trial - nil

Dr Amrita Kumari Pandey0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Amrita Kumari Pandey
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Amrita Kumari Pandey

Eligibility Criteria

Inclusion Criteria

  • 1\.ICD\-10 or 11 criteria for schizophrenia
  • 2\.Positive and Negative Syndrome Scale (PANSS) more than 60 score
  • 3\.Patient or legally authorized representative willing to give informed consent
  • 4\.Two generations of the patient living in northern India
  • 5\.Schizophrenic patients who have not received any psychotropics

Exclusion Criteria

  • 1\.Concurrent substance use disorders
  • 2\.Neurological conditions
  • 3\.Other comorbid axis I psychiatric diagnoses
  • 4\.Severe unstable organic illnesses
  • 5\.Not able to give consent
  • 6\.Pregnant or lactating females

Outcomes

Primary Outcomes

Not specified

Similar Trials